Analyst Ratings for Hi Tech Pharmacal (HITK)
HITK Rating Summary
HITK Price Target Summary
- Highest: $42.00 (Canaccord Genuity)
- Lowest: $37.50 (CRT Capital)
- Average: $40.50
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$40.50 (+20%)
Avg. $ Target:
$40.50 (+20%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/14/2013 | Standpoint Research | Upgrade | Buy (Hold) |
42.00 (N/A) |
34.10 | 33.74 | -1.06% | Details |
| 7/25/2012 | CRT Capital | Upgrade | Buy (Fairly Valued) |
37.50 (N/A) |
31.64 | 33.74 | 6.64% | Details |
| 1/5/2012 | Canaccord Genuity » Updated 12/7/2012 |
New Coverage | Buy (N/A) |
42.00 (42.00) |
39.45 | 33.74 | -14.47% | Details |
| 12/5/2011 | Needham & Company » Updated 7/11/2012 |
Downgrade | Hold (N/A) |
N/A (N/A) |
49.60 | 33.74 | -31.98% | Details |
